Search alternatives:
significantly mediate » significantly mediated (Expand Search), significantly predicted (Expand Search), significantly mitigated (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
mediate decrease » mean decrease (Expand Search), mediated defense (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 1,501 - 1,520 results of 6,771 for search '(( significant ((clinical decrease) OR (linear decrease)) ) OR ( significantly mediate decrease ))', query time: 0.74s Refine Results
  1. 1501
    Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment.

    Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1502
    Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase.

    Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1503
    Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase.

    Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1504
    Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase.

    Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1505
    Mean lipid profile (mmol/L) upon completion of the experimental period.

    Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1506
    Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase.

    Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1507
    Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose tolerance test.

    Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1508
    Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 magnification, scale bar = 100 µm). Occasional clear vacuoles are present in all groups, with a marked increase in the negative control group. Quantitative analysis using ImageJ (% steatotic area) more accurately reflects differences in hepatic fat accumulation as demonstrated in Fig 10D.

    Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1509
    Proposed model of how morphological plasticity contributes to echinocandin tolerance acquisition in <i>C. tropicalis</i> clinical isolates.

    Proposed model of how morphological plasticity contributes to echinocandin tolerance acquisition in <i>C. tropicalis</i> clinical isolates. by Yongqin Wu (272012)

    Published 2025
    Save to List
    Saved in:
  10. 1510
    Assessing Quality of Referrals to a Community-Based Chronic Pain Clinic

    Assessing Quality of Referrals to a Community-Based Chronic Pain Clinic by Angela Mailis (19960223)

    Published 2024
    “…<p>Because patients with chronic pain are complex, with significant medical and psychiatric comorbidities, referrals to specialty pain clinics are often necessary. …”
    Save to List
    Saved in:
  11. 1511
    FoxO3a-dependent mechanism of miR-150-5p in regulating pyroptosis in ox-LDL-stimulated RAW264.7 macrophages. (A-E) FoxO3a and ARC expression analyzed by (A-C) RT-qPCR and (D-E) Western blot. (F) FoxO3a mRNA levels quantified by RT-qPCR. (G) Immunofluorescence localization of FoxO3a (green) with DAPI nuclear counterstain (blue). Scale bar: 100 μm. (H) TUNEL assay detecting DNA fragmentation (red) with DAPI counterstain (blue). Scale bar: 100 μm. (I) RT-qPCR analysis of pyroptosis-related genes (NLRP3, ASC, Caspase-1). (J) Immunofluorescence visualization of Caspase-1 activation (green) with DAPI (blue). Scale bar: 100 μm. (K) Secreted IL-1β and IL-18 levels measured by ELISA. A: ox-LDL + NC; B: ox-LDL+inhibitor; C: ox-LDL+inhibitor+Vector; D: ox-LDL+inhibotor+si FoxO3a. Data are described with mean±SD of at least 3 diferent experiments. ns = not signifcant; *P < 0.05; **P < 0.01; ***P < 0.

    FoxO3a-dependent mechanism of miR-150-5p in regulating pyroptosis in ox-LDL-stimulated RAW264.7 macrophages. (A-E) FoxO3a and ARC expression analyzed by (A-C) RT-qPCR and (D-E) Wes... by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1512
    Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development.

    Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1513
    Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS).

    Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1514
    Experimental workflow for isolation and characterization of vascular tissue-derived exosomes.

    Experimental workflow for isolation and characterization of vascular tissue-derived exosomes. by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1515
    ox-LDL stimulates cytotoxicity and pyroptosis among RAW264.7.

    ox-LDL stimulates cytotoxicity and pyroptosis among RAW264.7. by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1516
    S4 Minimal Data Set. Pzfx.

    S4 Minimal Data Set. Pzfx. by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1517
    Resistant Starch Nanoparticles Induce Colitis through Lysosomal Exocytosis in Mice

    Resistant Starch Nanoparticles Induce Colitis through Lysosomal Exocytosis in Mice by Chenglu Peng (19935965)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1518
    Metabolic and molecular effects of high-fat diet (HFD).

    Metabolic and molecular effects of high-fat diet (HFD). by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1519
    miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE<sup>-/-</sup> mice.

    miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE<sup>-/-</sup> mice. by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1520
    Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages.

    Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: